The moral and fiscal implications of anti-retroviral therapies for HIV in Africa

書誌詳細
主要な著者: Sterck, O, Collier, P, Manning, R
フォーマット: Working paper
出版事項: University of Oxford 2015
_version_ 1826292555724095488
author Sterck, O
Collier, P
Manning, R
author_facet Sterck, O
Collier, P
Manning, R
author_sort Sterck, O
collection OXFORD
description
first_indexed 2024-03-07T03:16:31Z
format Working paper
id oxford-uuid:b5f81bd7-ff24-41b2-90ad-38f446fc26cd
institution University of Oxford
last_indexed 2024-03-07T03:16:31Z
publishDate 2015
publisher University of Oxford
record_format dspace
spelling oxford-uuid:b5f81bd7-ff24-41b2-90ad-38f446fc26cd2022-03-27T04:37:37ZThe moral and fiscal implications of anti-retroviral therapies for HIV in AfricaWorking paperhttp://purl.org/coar/resource_type/c_8042uuid:b5f81bd7-ff24-41b2-90ad-38f446fc26cdBulk import via SwordSymplectic ElementsUniversity of Oxford2015Sterck, OCollier, PManning, R
spellingShingle Sterck, O
Collier, P
Manning, R
The moral and fiscal implications of anti-retroviral therapies for HIV in Africa
title The moral and fiscal implications of anti-retroviral therapies for HIV in Africa
title_full The moral and fiscal implications of anti-retroviral therapies for HIV in Africa
title_fullStr The moral and fiscal implications of anti-retroviral therapies for HIV in Africa
title_full_unstemmed The moral and fiscal implications of anti-retroviral therapies for HIV in Africa
title_short The moral and fiscal implications of anti-retroviral therapies for HIV in Africa
title_sort moral and fiscal implications of anti retroviral therapies for hiv in africa
work_keys_str_mv AT stercko themoralandfiscalimplicationsofantiretroviraltherapiesforhivinafrica
AT collierp themoralandfiscalimplicationsofantiretroviraltherapiesforhivinafrica
AT manningr themoralandfiscalimplicationsofantiretroviraltherapiesforhivinafrica
AT stercko moralandfiscalimplicationsofantiretroviraltherapiesforhivinafrica
AT collierp moralandfiscalimplicationsofantiretroviraltherapiesforhivinafrica
AT manningr moralandfiscalimplicationsofantiretroviraltherapiesforhivinafrica